Cite

HARVARD Citation

    Stremska, M. et al. (2019). IL233, an IL-2-IL-33 hybrid cytokine induces prolonged remission of mouse lupus nephritis by targeting Treg cells as a single therapeutic agent. Journal of autoimmunity. pp. 133-141. [Online]. 
  
Back to record